Posts by vivapaul

Positive step for Vaccination in Queensland

The Pharmacy Guild of Australia has today congratulated the Queensland Government on allowing pharmacists to administer flu vaccinations to patients over the age of 16. VIVA! Communications also supports this fantastic initiative that will increase the number of patients in Queensland who can benefit from access to vaccination by trained pharmacists in their local community…

Read More

2019 – 2020 ‘Championing Change’ Innovation Practice Nurse Grants now open

Applications are now open for Seqirus Australia’s 2019-2020 ‘Championing Change’ Innovation Practice Nurse Grants. Now in their second year, the Innovation Grants recognise and support Australian practice nurses’ enhancement of community immunity through the implementation of innovative adult immunisation initiatives designed to boost coverage rates, or improve the quality use of adult vaccines. Immunisation providers…

Read More

Osteoporosis Australia CEO clinches 2019 IOF President’s Award at World Congress on Osteoporosis

Osteoporosis Australia’s CEO clinched the prestigious 2019 International Osteoporosis Foundation (IOF) President’s Award for his exceptional contribution to the bone field at the World Congress of Osteoporosis in Paris on April 5, 2019. Mr Greg Lyubomirsky is only the third Australian to receive the award, which acknowledges one’s outstanding commitment and contribution to advancing education…

Read More

Tim Goddard appointed President of GLOBALHealthPR®

Tim Goddard was today appointed President of GLOBALHealthPR® (GHPR) – the world’s largest partnership of independent healthcare-focused communication agencies.  Mr Goddard, who served as GHPR’s Executive Vice President over the past two years, will from today assume additional responsibilities as President. He will oversee the network’s strategy, business development, partner relations and growth.    He…

Read More

New relief may be on the way for people with inflammatory bowel disease (IBD)

A new study published earlier this month in Science Translational Medicine, may provide relief to millions of people around the world diagnosed with inflammatory Bowel Disease (IBD), who do not positively respond to standard treatment and drug therapies. IBD is a collective term used to describe all disorders that cause chronic inflammation within the gastrointestinal…

Read More